# Phase Ⅲ, Clinical Trial to Compare an Inactivated Quadrivalent Influenza Vaccine and a Licensed Vaccine in Chile

> **NCT05494047** · PHASE3 · UNKNOWN · sponsor: **Pontificia Universidad Catolica de Chile** · enrollment: 1600 (estimated)

## Conditions studied

- Influenza
- Vaccines

## Interventions

- **DRUG:** Tetravalent influenza vaccine developed by Sinovac Biotech Co.

## Key facts

- **NCT ID:** NCT05494047
- **Lead sponsor:** Pontificia Universidad Catolica de Chile
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-14
- **Primary completion:** 2023-05-31
- **Final completion:** 2023-07-31
- **Target enrollment:** 1600 (ESTIMATED)
- **Last updated:** 2022-08-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05494047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05494047, "Phase Ⅲ, Clinical Trial to Compare an Inactivated Quadrivalent Influenza Vaccine and a Licensed Vaccine in Chile". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05494047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*